Last reviewed · How we verify

NCT06941883

Ultrasound-Guided Versus Anatomically Guided Botulinum Toxin Injection in Spasticity in Adults in Tanta University Hospitals

Completed Last updated 24 April 2025
What this trial tests

trial testing Botulinum toxin injection under anatomical landmark in Ultrasound in 68 participants. Completed in 31 July 2024.

Timeline
16 July 2023
Primary endpoint
31 July 2024
31 July 2024

Quick facts

Lead sponsorTanta University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment68
Start date16 July 2023
Primary completion31 July 2024
Estimated completion31 July 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

18 and older, any sex, with Ultrasound or Botulinum Toxin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to compare the safety and outcome of ultrasound (US)- guided botulinum toxin (BoNT) injection and anatomically guided injection in muscle spasticity of different causes in adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ultrasound

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06941883.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing